[{"AccountsPayableCurrent_0_Q3_USD":4290000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":2000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-6000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":-5000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":-34000.0,"OtherLiabilitiesCurrent_0_Q3_USD":95000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1897000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-1651000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-5050000.0,"PaymentsForRestructuring_3_Q3_USD":1076000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":0.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":54000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":365000.0,"PaymentsToAcquireInvestments_3_Q3_USD":30784000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":954000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"OtherAssetsNoncurrent_0_Q3_USD":211000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":4265000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":323000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":59492000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":27122000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":61362000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-66589000.0,"NetIncomeLoss_1_Q3_USD":-26009000.0,"NetIncomeLoss_3_Q3_USD":-71935000.0,"OperatingExpenses_1_Q3_USD":32198000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"OperatingExpenses_3_Q3_USD":86617000.0,"OperatingIncomeLoss_3_Q3_USD":-66885000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":21802000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q3_USD":1931000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":1981000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":2031000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":1813000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q3_USD":13723000.0,"OperatingIncomeLoss_1_Q3_USD":-24358000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":1613344.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":4.9,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":2062907.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q3_USD":5.41,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_Q3_shares":220425.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":7.43,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3_Q3_USD":5.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.763,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":100000.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_3_Q3_shares":71782.0,"ShortTermInvestments_0_Q3_USD":33491000.0,"StockholdersEquity_0_Q3_USD":-2461000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_3_Q3_USD":0.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":2962000.0,"WarrantsAndRightsOutstanding_0_Q3_USD":68000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0114,"LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":0.0,"ShareBasedCompensation_3_Q3_USD":8638000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":26535000.0,"PrepaidExpenseCurrent_0_Q3_USD":3582000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":27000000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":0.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":93100000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":167000.0,"ProceedsFromStockPlans_3_Q3_USD":374000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6682000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":71539000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":15078000.0,"RestructuringAndRelatedCostExpectedCost1_0_Q3_USD":2000000.0,"RestructuringCharges_3_Q3_USD":275000.0,"RestructuringReserveCurrent_0_Q3_USD":10000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-409320000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":11035000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":27921000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":5663000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":66497593.0,"LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":0.0,"LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":14500000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockSharesIssued_0_Q3_shares":66497895.0,"CommonStockSharesOutstanding_0_Q3_shares":66497895.0,"CommonStockValue_0_Q3_USD":7000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-26015000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-71967000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":3220000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":8429000.0,"DebtInstrumentFaceAmount_0_Q3_USD":90675000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":0.0,"DeferredRentCreditNoncurrent_0_Q3_USD":6826000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":980000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.39,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":21894000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":59492000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":33491000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":33494000.0,"AccountsReceivableNet_0_Q3_USD":13561000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-353000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":22957000.0,"AccruedMarketingCostsCurrent_0_Q3_USD":1077000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-26000.0,"AdditionalPaidInCapital_0_Q3_USD":406878000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q3_USD":1000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.11,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3665000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8638000.0,"AmortizationOfFinancingCosts_3_Q3_USD":727000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":22587111.0,"Assets_0_Q3_USD":131260000.0,"AssetsCurrent_0_Q3_USD":124367000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":3000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3665000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":-1000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":11467000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":7900000.0,"InterestPaidNet_3_Q3_USD":5350000.0,"InterestPayableCurrent_0_Q3_USD":813000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":3114000.0,"InventoryNet_0_Q3_USD":14241000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":5184000.0,"InventoryValuationReserves_0_Q3_USD":2400000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":5943000.0,"InterestIncomeOther_3_Q3_USD":243000.0,"Investments_0_Q3_USD":33491000.0,"LeaseAndRentalExpense_3_Q3_USD":1800000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1400000.0,"Liabilities_0_Q3_USD":133721000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":131260000.0,"LiabilitiesCurrent_0_Q3_USD":37285000.0,"LongTermDebt_0_Q3_USD":87713000.0,"LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_0_Q3_USD":47175000.0,"LeaseAndRentalExpense_1_Q3_USD":600000.0,"LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":29000000.0,"InterestIncomeOther_1_Q3_USD":66000.0,"InterestExpense_1_Q3_USD":1798000.0,"EntityListingParValuePerShare_3_Q3_USD":0.0001,"FairValueAdjustmentOfWarrants_1_Q3_USD":-81000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":-91000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":0.0,"GrossProfit_1_Q3_USD":7840000.0,"GrossProfit_3_Q3_USD":19732000.0,"IncomeLossAttributableToParent_1_Q3_USD":-26009000.0,"InterestExpense_3_Q3_USD":5384000.0,"IncomeLossAttributableToParent_3_Q3_USD":-71935000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1173000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":6686000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":4650000.0,"IncreaseDecreaseInInventories_3_Q3_USD":5144000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":62000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":386000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":64722552.0,"Ticker":"XERS","CIK":"1867096","name":"XERIS BIOPHARMA HOLDINGS, INC.","OfficialName":"Xeris Biopharma Holdings Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"325256426.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]